World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Israel
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
98
Citations
33780
World Ranking
1669
National Ranking
16

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Israel Leader Award
  • 2022 - Research.com Biology and Biochemistry in Israel Leader Award

Overview

Leo Sachs is affiliated with the Weizmann Institute of Science in Israel and has contributed to research spanning several interdisciplinary fields. Their work engages with areas such as Environmental Science, Medicine, and Agricultural and Biological Sciences, reflecting a broad scientific focus. The research subfields associated with their work include Ecology, Endocrinology, Diabetes and Metabolism, and Aquatic Science.

Their recent publication record includes a paper titled Differential effects of 3,5-T2 and T3 on the gill regeneration and metamorphosis of the Ambystoma mexicanum (axolotl), published in 2023 in the journal Frontiers in Endocrinology. This article explores physiological and biochemical adaptations relating to thyroid hormones and amphibian development.

Leo Sachs's research covers several main topics, including:

  • Physiological and biochemical adaptations
  • Thyroid Disorders and Treatments
  • Aquaculture Nutrition and Growth

Frequent collaborators in their work include:

  • Iván Lazcano
  • Aurora Olvera
  • Santiago M. Pech-Pool
  • Nicolas Buisine
  • Aurea Orozco

Their publications have appeared in notable scientific venues, with Frontiers in Endocrinology being a key outlet for their recent paper. This indicates a focus on endocrinological aspects within their research portfolio.

Best Publications

  • Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

    E Yonish-Rouach;D Resnitzky;J Lotem;L Sachs

  • The cloning of normal “Mast” cells in tissue culture

    Dov H. Pluznik;Leo Sachs

  • Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia

    Leo Sachs

  • INTERACTION OF THE CARBOHYDRATE-BINDING PROTEIN CONCANAVALIN A WITH NORMAL AND TRANSFORMED CELLS

    Michael Inbar;Leo Sachs

  • In Vitro Transformation of Normal Cells to Tumor Cells by Carcinogenic Hydrocarbons

    Yoheved Berwald;Leo Sachs

  • In vitro control of the development of macrophage and granulocyte colonies.

    Yasuo Ichikawa;Dov H. Pluznik;Leo Sachs

  • The induction of clones of normal mast cells by a substance from conditioned medium.

    D.H. Pluznik;L. Sachs

  • Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis.

    Benny Motro;Ahuva Itin;Leo Sachs;Eli Keshet

  • Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.

    Joseph Lotem;Leo Sachs

  • Control of programmed cell death in normal and leukemic cells: new implications for therapy

    L Sachs;J Lotem

  • Hematopoietic Cells From Mice Deficient in Wild-Type p53 Are More Resistant to Induction of Apoptosis by Some Agents

    Joseph Lotem;Leo Sachs

  • Structural difference in sites on the surface membrane of normal and transformed cells.

    Michael Inbar;Leo Sachs

  • In Vitro Cell Transformation with Chemical Carcinogens

    Yoheved Berwald;Leo Sachs

  • Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1

    Gad Asher;Joseph Lotem;Batya Cohen;Leo Sachs

  • Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces.

    Halina Lis;Ben-Ami Sela;Leo Sachs;Nathan Sharon

  • In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients.

    Michael Paran;Leo Sachs;Yigal Barak;Peretz Resnitzky

  • Cell-mediated mutagenesis of mammalian cells with chemical carcinogens.

    Eliezer Huberman;Leo Sachs

  • The molecular control of blood cell development.

    Leo Sachs

  • Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells.

    Joseph Lotem;Leo Sachs

  • Lysosomal destabilization in p53-induced apoptosis

    Xi-Ming Yuan;Wei Li;Helge Dalen;Joseph Lotem

Frequent Co-Authors

Joseph Lotem
Joseph Lotem Weizmann Institute of Science
Eliezer Huberman
Eliezer Huberman University of Illinois at Chicago
Rabi Simantov
Rabi Simantov Weizmann Institute of Science
Israel Vlodavsky
Israel Vlodavsky Technion – Israel Institute of Technology
Yosef Shaul
Yosef Shaul Weizmann Institute of Science
Halina Lis
Halina Lis Weizmann Institute of Science
Nathan Sharon
Nathan Sharon Weizmann Institute of Science
Michael Feldman
Michael Feldman Weizmann Institute of Science
Urs Rutishauser
Urs Rutishauser Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Leo Sachs

Recently Published Articles